Detailed map of natural killer cells in COVID-19 patients expands understanding of innate immune response to SARS-CoV-2

August 21, 2020

A new study of 27 patients hospitalized with COVID-19 has provided a detailed map of natural killer (NK) cell responses to SARS-CoV-2 infection, revealing that specific characteristics of NK cell activation associate with different levels of disease severity. The findings are consistent with previous reports that NK cells exist in lower frequencies in the blood of patients with COVID-19 compared with healthy controls, but also show that increased numbers of certain NK cell types - adaptive NK cells specifically - correlate with severe, but not moderate, disease. Compared with adaptive immune cell responses to SARS-CoV-2, much less is known about the quick-acting innate immune response to SARS-CoV-2 and how it influences the course of disease. NK cells are innate immune cells located in the blood and abundantly in the lungs, where they act not only as rapid responders to viral infection, but also as influencers of adaptive immune responses: depending on their levels of activation, the unique "adaptive NK cell" subset can help T cells either control infection or contribute to disease.

To investigate whether NK cells' virus-controlling roles extend to SARS-CoV-2, Christopher Maucourant and colleagues analyzed NK cells taken from the blood of 27 patients with either severe or moderate COVID-19 and 17 healthy controls. They observed that NK cells were severely reduced but strongly activated in the blood of patients with COVID-19 compared with controls. The "arming" of these activated NK cells with cytotoxic effector proteins correlated with the development of severe disease, the researchers found. An additional high-dimensional analysis showed that patients with severe - but not moderate - COVID-19 harbored higher numbers of adaptive NK cells than healthy controls. Adaptive NK cells are thought to arise with cytomegalovirus (CMV) infection and remain afterward to act against future viral infections; indeed, the researchers observed the expansion of adaptive NK cells only in CMV-seropositive individuals among the COVID-19 cohort. Based on their findings, Maucourant et al. suggest several directions for future work on the role of NK cells in COVID-19, including whether NK cell activation states identified in the blood can also be found in the lungs, and how NK cell responses vary at different time points during SARS-CoV-2 infection.
-end-


American Association for the Advancement of Science

Related Infection Articles from Brightsurf:

Halving the risk of infection following surgery
New analysis by the University of Leeds and the University of Bern of more than 14,000 operations has found that using alcoholic chlorhexidine gluconate (CHG) halves the risk of infection in certain types of surgery when compared to the more commonly used povidone-iodine (PVI).

How plants shut the door on infection
A new study by an international team including University of Maryland scientists has discovered the key calcium channel responsible for closing plant pores as an immune response to pathogen exposure.

Sensing infection, suppressing regeneration
UIC researchers describe an enzyme that blocks the ability of blood vessel cells to self-heal.

Boost to lung immunity following infection
The strength of the immune system in response to respiratory infections is constantly changing, depending on the history of previous, unrelated infections, according to new research from the Crick.

Is infection after surgery associated with increased long-term risk of infection, death?
Whether experiencing an infection within the first 30 days after surgery is associated with an increased risk of another infection and death within one year was the focus of this observational study that included about 660,000 veterans who underwent major surgery.

Revealed: How E. coli knows how to cause the worst possible infection
The discovery could one day let doctors prevent the infection by allowing E. coli to pass harmlessly through the body.

UK study shows most patients with suspected urinary tract infection and treated with antibiotics actually lack evidence of this infection
New research presented at this week's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Amsterdam, Netherlands (April 13-16, 2019) shows that only one third of patients that enter the emergency department with suspected urinary tract infection (UTI) actually have evidence of this infection, yet almost all are treated with antibiotics, unnecessarily driving the emergence of antimicrobial resistance.

Bacteria in urine doesn't always indicate infection
Doctors should think carefully before testing patients for a urinary tract infection (UTI) to avoid over-diagnosis and unnecessary antibiotic treatment, according to updated asymptomatic bacteriuria (ASB) guidelines released by the Infectious Diseases Society of America (IDSA) and published in Clinical Infectious Diseases.

Subsidies for infection control to healthcare institutions help reduce infection levels
Researchers compared three types of infection control subsidies and found that under a limited budget, a dollar-for-dollar matching subsidy, in which policymakers match hospital spending for infection control measures, was the most effective at reducing the number of hospital-acquired infections.

Dengue virus infection may cause severe outcomes following Zika virus infection during pregnancy
This study is the first to report a possible mechanism for the enhancement of Zika virus progression during pregnancy in an animal model.

Read More: Infection News and Infection Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.